Bariatric Surgery May Improve Outcomes for Obese Patients with Inflammatory Bowel Disease
New research reveals that bariatric surgery can significantly improve inflammatory bowel disease outcomes in obese patients, offering a promising integrated treatment approach.
Recent research suggests that bariatric surgery could play a beneficial role in managing inflammatory bowel disease (IBD) among patients with obesity. A comprehensive study published online on July 22 in BJS Open examined the impact of surgical weight loss procedures on IBD outcomes. The study was led by Dr. Erik Stenberg from Örebro University in Sweden and involved a nationwide cohort of adult Swedish patients with both obesity and IBD, spanning from 2007 to 2020.
The research included 798 patients, with half undergoing bariatric surgery—either sleeve gastrectomy or Roux-en-Y gastric bypass—and the other half serving as controls. Over the follow-up period, those who had surgery experienced significantly fewer events indicative of IBD worsening, such as hospitalizations, initiation of corticosteroids or immunomodulators, and major disease-related surgeries. Specifically, the primary composite endpoint occurred in 201 patients with surgery compared to 226 without, reflecting a hazard ratio of 0.66, which signifies a 34% reduction in risk.
Importantly, both types of bariatric procedures showed a trend toward reducing IBD complications, but the statistically significant results were primarily associated with Roux-en-Y gastric bypass. These findings indicate that bariatric surgery might be a useful intervention not only for weight loss but also for reducing the severity and progression of IBD in obese patients.
This research underscores the potential dual benefits of bariatric surgery for individuals suffering from obesity and IBD, illuminating new avenues for comprehensive treatment strategies. For more detailed information, refer to the original study in BJS Open at this link.
Source: https://medicalxpress.com/news/2025-08-bariatric-surgery-linked-ibd-outcomes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into How the Immune System Fights Gut Parasites
A groundbreaking study uncovers how the immune system combats gut parasites using a protein called Gasdermin C, opening avenues for repurposing drugs like NSAIDs to treat parasitic infections.
The Link Between Physical Performance, Cognitive Function, and Functional Capacity in Multiple Sclerosis Patients
New research reveals a strong link between physical performance, cognitive skills, and functional capacity in patients with relapsing-remitting multiple sclerosis, emphasizing the importance of regular physical and cognitive assessments.
Majority of Americans Oppose Cuts to Medicare and Medicaid, Poll Finds
Most Americans, across political and demographic lines, oppose proposed federal cuts to Medicare and Medicaid programs, highlighting widespread support for maintaining essential healthcare services.
Uncommitted Cancer Cells May Offer Hope for Neuroblastoma Patients
Research reveals that a population of 'uncommitted' cells in neuroblastoma tumors may explain spontaneous regressions, offering hope for improved prognosis and therapeutic approaches. Discover the latest findings in tumor cell states and neuroblastoma outcomes.